Came across this by chance in Dubai - never realised that an NHS hospital had a ‘branch’ in Dubai + proudly boasts that many of the staff are recruited from the NHS. At a time of long w/lists, bed waits and low morale not sure this is what our NHS hospitals should be supporting.

Thrilled that active surveillance for #BladderCancer has made it into #EAU23 Guidelines European Association of Urology (EAU) Paolo Gontero Morgan Roupret

Watch out for data from Wei Shen Tan IBCG Roberto Contieri Valentina Grajales MD, MS MD Anderson Cancer Center on this topic

YUO Amer. Urol. Assn. Bladder Cancer Advocacy Network Society of Urologic Oncology

Editor's Choice: Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours

euoncology.europeanurology.com/article/S2588-…

Hugh Mostafid Ashish M. Kamat, MD, MBBS Sia Daneshmand, M.D. Joan Palou Redorta james mckiernan jim catto

#Editorschoice #bladder #UroOnco

Bladder Cancer Review: Epidemiology, Screening, and Prevention of Bladder Cancer

buff.ly/3FQ5Izv

Niyati Lobo Luca Afferi Marco Moschini Hugh Mostafid Sima Porten Sarah P. Psutka MD MS Shilpa Gupta Angie Smith Stephen B. Williams, MD, MBA, MS, FACS

#bladdercancer #review #UroOnco #MedTwitter

Editor Pick: Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours

buff.ly/30gMH3m

Hugh Mostafid Ashish M. Kamat, MD, MBBS Joan Palou Redorta james mckiernan jim catto

#bladdertumours #MedTwitter #urology

The evidence for role of neoadjuvant therapy in NMIBC continues to mount

2 doses of NAC with MMC reduced risk of recurrence by 63%: Journal of Urology auajournals.org/doi/10.1097/JU…

Intensive MMC – 3/wk x 2 wks – reduced need for TURBT in 57% patients sciencedirect.com/science/articl…

#BladderCancer

I have used this strategy in patients unable to undergo TURBT (eg recovering from acute MI) or to debulk certain tumors prior to TURBT

Hugh Mostafid jim catto Joan Palou Redorta Gary Steinberg Wes Kassouf Stephen B. Williams, MD, MBA, MS, FACS Maria J. Ribal Angie Smith Morgan Roupret Petros Grivas IBCG

Happy to share our preprint investigating chemoablation in recurrent non-muscle invasive bladder cancer. ⁦Journal of Clinical Oncology⁩ ⁦Jørgen Bjerggaard⁩ ⁦Lars Dyrskjøt⁩ ⁦Nessn Azawi⁩ ascopubs.org/journal/jco

Iranian women are among the most educated and accomplished around the world. Help support the movement #mahsaamini #womenofiran #womensrights #iranpotests instagram.com/p/CjN0fKorqXJ/…

10/ Massive thanks to the team Hugh Mostafid Prof Param Mariappan FRCS(Urol), PhD Newcastle University NU Medical Research The ICR Prof Emma Hall HSRU gsmaclennan James N'Dow University of Aberdeen Matt Breckons Giovany Orozco Leal | BLM 🇨🇴 Jo Cresswell Dr Emma Clark John Kelly UCLH Robotics zafer tandogdu

Hyperthermic chemo does not improve DFS in intermediate risk NMIBC: DFS @ 24 mos: 61% vs 60%

Conclusive results from HIVEC-II RCT : led by Wei Shen Tan while at @UCLH - now Society of Urologic Oncology MD Anderson Cancer Center

Hugh Mostafid Rami Issa Barts Cancer Institute European Urology

sciencedirect.com/science/articl… #bladdercancer

#EAU22 Join us next Saturday for a terrific #ESOU #ERUS #ESUT session on controversies in uro-oncology

Crème de la crème faculty, hot debates and interaction!

It'll be great fun to chair live with 🇫🇷 Morgan Roupret & 🇪🇸Carme Mir after some time!

You wouldn't want to miss it!

Come join us in August for our inaugural workshop on Endoscopic Bladder Cancer Surgery WGH Connect #EBCSatEBCS Jo Cresswell Prof Param Mariappan FRCS(Urol), PhD Hugh Mostafid @PelvicERAS Prashant Patel KARL STORZ - UK @PhotocureAS medac Pharma BSoT
..and Enjoy The Edinburgh Festival!

Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria

buff.ly/3Kw43zm

🇮🇳 Bhavan Rai 🇬🇧 Imran Omar Hugh Mostafid Viktor Soukup Philippe Violette

Congratulations ⁦🇮🇳 Bhavan Rai 🇬🇧⁩ ⁦Imran Omar⁩ ⁦Hugh Mostafid⁩ & co on this important systematic review of incidence & risk factors for urothelial ca & RCC in #haematuria #hematuria 👏🏻
Building evidence to improve our diagnostic pathways 💪🏻 sciencedirect.com/science/articl…

Thanks Olympus Medical UKIE for sharing this #HealthcareConvo about our top three priorities for #BladderCancer diagnosis, treatment and care.

Would you add anything else to the list?

#BladderCancer Awareness #CancerAwareness Hugh Mostafid

New #UROwebinar by Profs. Paolo Gontero, Hugh Mostafid & Van Rhijn next week!

Learn about new system that uses data from a large series of Ta-T1 NMIBCs & able to stratify pts w/ progression rate from 1% (low risk) to 40% (very high risk).

Register now👉ow.ly/wnZC50IbqaJ